NCT07442617Completed
Bridging the Gap Between Prescription and Practice: Impact of Nurse-Led Inhaler Education
Bridging the Gap Between Prescription and Practice: Impact of Nurse-Led Inhaler Education on Patient Technique, Knowledge, Adherence, and Beliefs - A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 2 Mar 2026
Brief summary (registry, in English)
Asthma and chronic obstructive pulmonary disease (COPD) are among the most prevalent chronic respiratory conditions worldwide, affecting hundreds of millions of individuals and contributing substantially to morbidity, mortality, and healthcare burden. Although clinicians routinely advise patients verbally on inhaler use, the lack of structured, hands-on education results in significant variation in technique and consistently poor retention of skills over time.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 24 Feb 2026
- Start date
- 1 Dec 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Mansoura University Hospital
- Diseases
- Asthma
- NCT number
- NCT07442617
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 1 Dec 2025 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment or neurological disorders preventing understanding or proper inhaler use.
- Severe comorbidities (e.g., advanced heart failure, end-stage renal disease) that limit participation.
Other
- Acute exacerbation requiring hospitalization at the time of enrollment.
Who the study is looking for
- Adults aged ≥18 years diagnosed with Asthma or COPD according to GINA / GOLD guidelines
- Current use of inhaler therapy (MDI, DPI, or Nebulizer) for ≥3 months.
- Able to understand instructions and perform inhaler technique assessments.
- Willing to provide informed consent and participate in all study assessments.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mohamed AbdElmoniem Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.